Now Enrolling: Pneumonia Vaccine Research Study for Adults 50+

AMR Clinical Miami is now enrolling adults ages 50 and older in an investigational pneumonia vaccine research study.

Qualified participants:

Are 50 to 64 and have never received a pneumonia vaccine OR

Are 65+ and have either never received a pneumonia vaccine or received a Pneumovax 23 vaccine more than 5 years ago.

Meet other study criteria .

Qualified participants will receive all study-related care and investigational vaccine at no cost. Compensation is available up to $362.50 for study-related time and travel.

If you're interested in learning more about this trial, you can reach out to AMR today by calling (786) 724-0750 or visit their website at www.amr-clinical.com for more detailed information.